Temporomandibular Joint Syndrome

Back

Background

The temporal mandibular joint (TMJ) is the synovial joint that connects the jaw to the skull. These two joints are located just in front of each ear. Each joint is composed of the condyle of the mandible, an articulating disk, and the articular tubercle of the temporal bone. The movements allowed are side to side, up and down, as well as protrusion and retrusion. This complicated joint, along with its attached muscles, allows movements needed for speaking, chewing, and making facial expressions.

Pain and functional disturbances related to the TMJ are common.[1] Uyanik et al identifies the following three distinct causes of pain at the TMJ, which collectively fall under the broader term of TMJ syndrome[2] :

See also Temporomandibular Disorders.

Pathophysiology

The pathophysiology of TMJ syndrome is not entirely understood. It is believed that the etiology is likely multifactorial and arises from both local insults and systemic disorders. Local problems frequently arise from articular disc displacement and hereditary conditions affecting the structures of the joint itself, such as hypoplastic mandibular condyles. A study by Tallents et al found TMJ displacement in 84% of patients with symptomatic TMJ versus 33% of asymptomatic subjects.[3]

The TMJs can also be affected by conditions such as rheumatoid arthritis, juvenile idiopathic arthritis,[4] osteoarthritis, and diseases of the articular disks. In addition, hypermobile TMJs, nocturnal jaw clenching, nocturnal bruxism, jaw clenching due to psychosocial stresses, and local trauma also play a significant role.

A study of 299 females aged 18-60 years suggests that compared with nonsmokers, female smokers younger than 30 years had a higher risk of temporomandibular disorder than older adults.[5]

As described by Hegde, a strong understanding of how the trigeminal nerve innervates the TMJ and surrounding structures explains the pain and referred pain patterns of TMJ disorders.[6] Irritation of the mandibular branch (V3) of the trigeminal nerve results in pain locally at the TMJ and also to other areas of V3 sensory innervation, which include the ipsilateral skin, teeth, side of the head, and scalp.

Epidemiology

Frequency

United States

Currently, an estimated 10 million people have TMJ disorders, and roughly 25% of the population have symptoms at some point in their lives.

Mortality/Morbidity

The morbidity of the disorder is related to significant pain on movement of the jaw. While some patients' symptoms may resolve within weeks, others may have chronic symptoms that persist even with extensive therapy.

One study by Rammelsberg et al followed 235 patients over 5 years.[7] In this study, roughly one third of patients had completely resolved pain, one third had continuous pain over the 5 years, and one third had recurrent episodes with periods of remission.

Race-, Sex-, and Age-related Demographics

See the list below:

History

Symptoms of temporomandibular joint syndrome consist of the following:

Physical

Characteristic findings on physical examination include the following:

Laboratory Studies

No laboratory studies are specifically indicated to rule in temporomandibular joint (TMJ) syndrome; however, appropriate laboratory samples may be drawn to help rule out other disorders, as follows:

Imaging Studies

Imaging studies generally are not indicated in the emergency department, unless a fracture is suspected. Considerations are as follows:

For more information, see Imaging of Meniscus Abnormalities in the Temporomandibular Joint.

Diagnostic Nerve Block

The auriculotemporal branch of the trigeminal nerve provides the sensory innervation of the TMJ. A diagnostic nerve block of the auriculotemporal nerve can be helpful in differentiating whether the unilateral orofacial pain originates in the TMJ capsule.[9]

To perform a diagnostic anesthesia block, use a 25- to 30-gauge needle and inject 0.5 mL of short-acting anesthetic about 0.5 inches below the skin just inferior and lateral to the mandibular condyle. If the patient does not experience pain relief with the nerve block, consider other causes of the orofacial pain.

Emergency Department Care

Signs and symptoms of temporomandibular joint (TMJ) disorders improve over time with or without treatment for most patients. As many as 50% of the patients have symptomatic improvement in 1 year and 85% in 3 years. The following conservative measures should be attempted before invasive therapies, such as orthodontics or surgery, are recommended[10] :

Consultations

Provide outpatient follow-up care with ear, nose, and throat (ENT) specialist or oral surgeon. However, if intractable pain is present, more urgent consultation is necessary.

Medication Summary

Nonsteroidal anti-inflammatory drugs (NSAIDs) and benzodiazepines are the mainstays of pharmacologic treatment for temporomandibular joint (TMJ) syndrome in the emergency deparment. Patients eventually may require tricyclics, opioids, muscle relaxants, or steroid (intra-articular) therapy for protracted pain syndromes.

Ibuprofen (Motrin, Advil, Ibuprin, Nuprin)

Clinical Context:  Usually DOC for treatment of mild to moderate pain if no contraindications exist; inhibits inflammatory reactions and pain, probably by decreasing activity of enzyme cyclooxygenase, which results in inhibition of prostaglandin synthesis.

Naproxen (Aleve, Anaprox, Naprosyn)

Clinical Context:  Used for relief of mild to moderate pain; inhibits inflammatory reactions and pain by decreasing activity of enzyme cyclooxygenase, which results in decrease of prostaglandin synthesis.

Flurbiprofen (Ansaid)

Clinical Context:  Analgesic, antipyretic, and anti-inflammatory effects; may inhibit cyclooxygenase enzyme, causing inhibition of prostaglandin biosynthesis that in turn may result in analgesic and anti-inflammatory activities.

Ketoprofen (Oruvail, Orudis, Actron)

Clinical Context:  Used for relief of mild to moderate pain and inflammation; administer small dosages initially to patients with small bodies, older persons, and those with renal or liver disease; doses >75 mg do not increase therapeutic effects; administer high doses with caution and closely observe patient for response.

Mefenamic acid (Ponstel)

Clinical Context:  Inhibits inflammatory reactions and pain by decreasing prostaglandin synthesis.

Indomethacin (Indocin, Indochron E-R)

Clinical Context:  Rapidly absorbed; metabolism occurs in liver by demethylation, deacetylation, and glucuronide conjugation; inhibits prostaglandin synthesis.

Piroxicam (Feldene)

Clinical Context:  Decreases activity of cyclooxygenase, which, in turn, inhibits prostaglandin synthesis; effects decrease formation of inflammatory mediators.

Class Summary

Most commonly used for relief of mild to moderate pain. Although effects of NSAIDs in treatment of pain tend to be patient specific, ibuprofen usually is the DOC for initial therapy. Other options include naproxen, flurbiprofen, mefenamic acid, ketoprofen, indomethacin, and piroxicam.

Diazepam (Valium)

Clinical Context:  Depresses all levels of CNS, including limbic and reticular formation, possibly by increasing activity of GABA, a major inhibitory neurotransmitter.

Individualize dosage and increase cautiously to avoid adverse effects.

Class Summary

Used for muscle relaxant properties but relatively contraindicated in pediatric patients because of sedating properties; appear to potentiate effects of GABA and facilitate inhibitory GABA neurotransmission and other inhibitory transmitters by binding to specific receptor sites.

Further Outpatient Care

Outpatient therapies for temporomandicular joint (TMJ) syndrome should begin with conservative measures and become more invasive when other options have been exhausted. Initial treatment may include the following:

If failure of these more conservative treatments occurs, operative repair may be considered. Operative repair can range from arthroscopic procedures, which can wash out the joint and allow for small repairs,[12] to open procedures. Open procedures can utilize jaw implants, synthetic articular disks, or total TMJ replacement with custom-made alloplastic prostheses.[13] With TMJ ankylosis associated with juvenile idiopathic arthritis, reconstruction with a costochondral graft is the gold standard.[14]

However, in a long-term study by Fricton et al, synthetic implants did not lead to an improved outcome compared with nonimplant surgical repair or nonsurgical rehabilitation.[15] This was determined by looking at subjective and objective measures of symptom severity and functional deficits.

Inpatient & Outpatient Medications

See the list below:

Complications

Complications may include the following:

Prognosis

See the list below:

Patient Education

Patient education measures may include the following:

What is temporomandibular joint (TMJ) syndrome?What causes pain in TMJ syndrome?What is the pathophysiology of TMJ syndrome?How prevalent is TMJ syndrome?What is the morbidity of TMJ syndrome?What are the demographics of TMJ syndrome?What are the symptoms of TMJ syndrome?What are the characteristic findings on physical exam in TMJ syndrome?What are the differential diagnoses for Temporomandibular Joint Syndrome?Which lab studies are indicated in the workup of TMJ syndrome?Which imaging studies are indicated in the workup of TMJ syndrome?What is the role of a diagnostic nerve block in the workup of TMJ syndrome?What is the initial treatment of TMJ syndrome?Which specialist consultations are indicated in the treatment of TMJ syndrome?Which medications are used in the treatment of TMJ syndrome?Which medications in the drug class Benzodiazepines are used in the treatment of Temporomandibular Joint Syndrome?Which medications in the drug class Nonsteroidal anti-inflammatory drugs (NSAIDs) are used in the treatment of Temporomandibular Joint Syndrome?What is the initial outpatient therapy for TMJ syndrome?What are the treatment options for TMJ syndrome if conservative measures fail?Which drugs are used in the treatment of TMJ syndrome?What are the complications of TMJ syndrome?What is the prognosis of TMJ syndrome?What patient education is indicated in the treatment of TMJ syndrome?

Author

Vivian Tsai, MD, MPH, FACEP, Assistant Professor of Emergency Medicine, Mount Sinai School of Medicine, Queens Hospital Center

Disclosure: Nothing to disclose.

Coauthor(s)

Richard H Sinert, DO, Professor of Emergency Medicine, Clinical Assistant Professor of Medicine, Research Director, State University of New York College of Medicine; Consulting Staff, Vice-Chair in Charge of Research, Department of Emergency Medicine, Kings County Hospital Center

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Pfizer Pharmaceutical<br/>Received research grant from: National Institutes Health.

Steven M Heffer, MD, Consulting Staff, Department of Emergency Medicine, Greenwich Hospital

Disclosure: Nothing to disclose.

Specialty Editors

Francisco Talavera, PharmD, PhD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Gino A Farina, MD, FACEP, FAAEM, Professor of Emergency Medicine, Hofstra North Shore-LIJ School of Medicine at Hofstra University; Program Director, Department of Emergency Medicine, Long Island Jewish Medical Center

Disclosure: Nothing to disclose.

Chief Editor

Herbert S Diamond, MD, Visiting Professor of Medicine, Division of Rheumatology, State University of New York Downstate Medical Center; Chairman Emeritus, Department of Internal Medicine, Western Pennsylvania Hospital

Disclosure: Nothing to disclose.

Acknowledgements

Jerome FX Naradzay, MD, FACEP Medical Director, Consulting Staff, Department of Emergency Medicine, Maria Parham Hospital; Medical Examiner, Vance County, North Carolina

Jerome FX Naradzay, MD, FACEP is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Joshua Parnes, MD Resident Physician, Department of Emergency Medicine, Kings County Hospital Center

Disclosure: Nothing to disclose.

References

  1. Yule PL, Durham J, Wassell RW. Pain Part 6: Temporomandibular Disorders. Dent Update. 2016 Jan-Feb. 43 (1):39-42, 45-8. [View Abstract]
  2. Uyanik JM, Murphy E. Evaluation and management of TMDs, Part 1. History, epidemiology, classification, anatomy, and patient evaluation. Dent Today. 2003 Oct. 22(10):140-5. [View Abstract]
  3. Tallents, RH, Katzberg, RW, Murphy W, Proskin, et al. Magnetic resonance imaging findings in asymptomatic volunteers and symptomatic patients with temporomandibular disorders. J Prosthet Dent. 1996. 75:529. [View Abstract]
  4. Frid P, Nordal E, Bovis F, Giancane G, Larheim TA, et al. Temporomandibular Joint Involvement in Association With Quality of Life, Disability, and High Disease Activity in Juvenile Idiopathic Arthritis. Arthritis Care Res (Hoboken). 2017 May. 69 (5):677-686. [View Abstract]
  5. Sanders AE, Maixner W, Nackley AG, Diatchenko L, By K, Miller VE, et al. Excess risk of temporomandibular disorder associated with cigarette smoking in young adults. J Pain. 2012 Jan. 13(1):21-31. [View Abstract]
  6. Hegde V. A review of the disorders of the temporomandibular joint. J Indian Prosthodont Soc. 2005. 5:56-61.
  7. Rammelsberg P, LeResche L, Dworkin S. Longitudinal outcome of temporomandibular disorders: a 5-year epidemiologic study of muscle disorders defined by research diagnostic criteria for temporomandibular disorders. J Orofac Pain. 2003. 17(1):9-20. [View Abstract]
  8. Ahn SJ, Kim TW, Lee DY. Evaluation of internal derangement of the temporomandibular joint by panoramic radiographs compared with magnetic resonance imaging. Am J Orthod Dentofacial Orthop. 2006 Apr. 129(4):479-85. [View Abstract]
  9. American Academy of Family Physicians. Temporomandibular join (TMJ) pain. Am Fm Physician. 2007 Nov. 76(10):1483-4. [View Abstract]
  10. [Guideline] American Society of Temporomandibular Joint Surgeons. Guidelines for diagnosis and management of disorders involving the temporomandibular joint and related musculoskeletal structures. Cranio. 2003 Jan. 21(1):68-76. [View Abstract]
  11. Venezian GC, da Silva MA, Mazzetto RG, Mazzetto MO. Low level laser effects on pain to palpation and electromyographic activity in TMD patients: a double-blind, randomized, placebo-controlled study. Cranio. 2010 Apr. 28(2):84-91. [View Abstract]
  12. Silva PA, Lopes MT, Freire FS. A prospective study of 138 arthroscopies of the temporomandibular joint. Braz J Otorhinolaryngol. 2015 Jul-Aug. 81 (4):352-7. [View Abstract]
  13. Briceño F, Ayala R, Delgado K, Piñango S. Evaluation of temporomandibular joint total replacement with alloplastic prosthesis: observational study of 27 patients. Craniomaxillofac Trauma Reconstr. 2013 Sep. 6 (3):171-8. [View Abstract]
  14. Felix VB, Cabral DR, de Almeida AB, Soares ED, de Moraes Fernandes KJ. Ankylosis of the Temporomandibular Joint and Reconstruction With a Costochondral Graft in a Patient With Juvenile Idiopathic Arthritis. J Craniofac Surg. 2017 Jan. 28 (1):203-206. [View Abstract]
  15. Fricton JR, Look JO, Schiffman E, Swift J. Long-term study of temporomandibular joint surgery with alloplastic implants compared with nonimplant surgery and nonsurgical rehabilitation for painful temporomandibular joint disc displacement. J Oral Maxillofac Surg. 2002 Dec. 60(12):1400-11; discussion 1411-2. [View Abstract]